Cavernous angioma epidemiology and demographics: Difference between revisions
Created page with "__NOTOC__ {{Cavernous angioma}} {{CMG}} Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing. ==Over..." |
No edit summary |
||
| Line 8: | Line 8: | ||
The incidence in the general population is between 0.1–0.5%, and clinical symptoms typically appear between 30 to 50 years of age. Once thought to be strictly congenital, these vascular lesions have been found to occur ''de novo''. | The incidence in the general population is between 0.1–0.5%, and clinical symptoms typically appear between 30 to 50 years of age. Once thought to be strictly congenital, these vascular lesions have been found to occur ''de novo''. | ||
==Age== | |||
Cavernous malformations can occur at any age, but they are most likely to become clinically apparent in patients aged 20-40 years. | |||
==References== | ==References== | ||
Revision as of 19:41, 3 December 2012
|
Cavernous angioma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cavernous angioma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Cavernous angioma epidemiology and demographics |
|
Risk calculators and risk factors for Cavernous angioma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
The incidence in the general population is between 0.1–0.5%, and clinical symptoms typically appear between 30 to 50 years of age. Once thought to be strictly congenital, these vascular lesions have been found to occur de novo.
Age
Cavernous malformations can occur at any age, but they are most likely to become clinically apparent in patients aged 20-40 years.